National and Kapodistrian University of Athens
Εικονικός βιολογικός έλεγχος βάσεων δεδομένων χημικών μορίων με τριδιάστατα μοντέλα ποσοτικών σχέσεων δομής-δράσης (3D-QSAR): εξερεύνηση καινοτόμων φαρμακευτικών μορίων για τη θεραπεία της ηπατίτιδας C και της μεσογειακής αναιμίας
Abstract
dc:descriptionThe aim of this dissertation was the in silico identification of new compoundsagainst hepatitis C and beta-thalassaemia diseases.Hepatitis C, caused by hepatitis C virus (HCV), mainly affects the liver andhas spread worldwide in recent decades. To date, no vaccine has beendiscovered against hepatitis C virus, while the current therapy is effective onlyin limited cases. The HCV NS5B RNA-dependent RNA polymerase is the keyfunction of the replication of viral RNA, constituting a therapeutic target ofdisease. Search of inhibitors of HCV NS5B RNA polymerase has led to theinvestigation of the nucleoside (NIs) and non-nucleoside inhibitors (NNIs),targeting on the catalytic site and allosteric sites (palm, thumb, fingers) of theenzyme, respectively. NNIs have attracted the particular interest ofresearchers.Molecular docking, 3D-QSAR CoMSIA and similarity search were combined ina multi-step framework with the ultimate goal to identify potent indole analogs,in the ChEMBL database, as inhibitors of HCV replication, in a virtualscreening procedure. Initially, 41 known inhibitors were docked into theenzyme ‘‘Palm II’’ active site. In a second step, the docking pose of eachcompound was used in a receptor-based alignment for the generation of theCoMSIA fields. A validated 3D-QSAR CoMSIA model was subsequently builtto accurately estimate the activity values. The proposed framework gaveinsight into the structural characteristics that affect the binding and theinhibitory activity of these derivatives on HCV polymerase. The obtained in silico model was used to predict the activity of novel compounds prior to theirsynthesis and biological testing, within a virtual screening procedure. TheChEMBL database was mined to afford 18 compounds containing the indolescaffold that are predicted to possess high activity and thus can be prioritizedfor biological screening.A similar combination of the computational methods: (i) molecular docking, (ii)3D-QSAR CoMFA, (iii) similarity search and (iv) virtual screening usingPubChem database was applied to identify new anthranilic acid-basedinhibitors of HCV replication. 53 known inhibitors were initially docked into the ‘‘Thumb Pocket 2’’ allosteric site of the crystal structure of the RNApolymerase. Then, the CoMFA fields were generated through a receptorbasedalignment of docking poses to build a validated and stable 3D-QSARCoMFA model. The proposed model was utilized to get insight into themolecular features that promote bioactivity, and then a virtual screeningprocedure was used to estimate the activity of novel potential bioactivecompounds.Beta-thalassaemia is a common blood disorder spread worldwide, thatreduces the production of hemoglobin (Hb). Pharmacological reactivation ofthe γ-globin gene for the production of fetal haemoglobin (HbF) is a verypromising therapeutic avenue for the disease. K562 human erythroleukemiccell line has the potential to highly express the γ- but not the β-globin gene.Erythroid differentiation of K562 cells is associated with an increase in theexpression of embryo-fetal globin genes such as ζ, ε, and γ-globin genes.This characteristic makes K562 cells a widely useful model cell line for thestudy of compounds that are potential γ-globin inducers for use β–thalassaemiaIn an attempt to aid the design of new chemotypes with enhanced cytotoxicityagainst K562 cells, 3D pharmacophore models were generated and 3DQSARCoMFA and CoMSIA studies were carried out on the 33 novel ABLkinase inhibitors (E)-α-benzylthio chalcones. BCR-ABL is a constitutivelyactive tyrosine kinase that is responsible for the malignant transformation andchronic myelogenous leukemia (CML). A five-point pharmacophore (AHHRR) with a hydrogen bond acceptor, two hydrophobic groups, and two aromaticrings as pharmacophore features, and a statistically significant 3D-QSARmodel with excellent predictive power were developed. The pharmacophoremodel was also used for alignment of 33 compounds in a CoMFA/CoMSIAanalysis. The contour maps of the fields of CoMFA and CoMSIA models wereutilized to provide structural insight into how these molecules promote theirtoxicity. The possibility of using this model for the design of drugs for thetreatment of β–thalassaemia since several BCR-ABL inhibitors are able topromote erythroid differentiation and γ–globin expression in CML cell linesand primary erythroid cells was discussed.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vrontaki, Eleni
- Βροντάκη, Ελένη
Subjects
dc:subject × 17Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44060